Backed Cirrus Therapeutics, a gene therapy company developing medicines for blinding eye diseases.
Cirrus Therapeutics is leveraging ocular immunology to create transformative therapies, designed to extend ocular healthspan and redefine healthy aging for vision
Cirrus Therapeutics is leveraging ocular immunology to create transformative therapies, designed to extend ocular healthspan and redefine healthy aging for vision. The company is focused on developing treatments for age-related macular degeneration (AMD) using innovative approaches that rejuvenate the eye's defenses across multiple pathways.